Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.
about
Gallbladder Cancer in the 21st Century.Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesExperience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinomaA multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.Chemotherapy and targeted therapy for gall bladder cancer.A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.Systemic Therapy of Cholangiocarcinoma.Guidelines for chemotherapy of biliary tract and ampullary carcinomasCurrent management of gallbladder carcinoma.SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Targeted therapy for biliary tract cancer.Current status of chemotherapy for the treatment of advanced biliary tract cancer.Capecitabine and Gemcitabine (CapGem, CG, GemCap) for Advanced Pancreatic and Biliary Tract Cancer.Genetics of biliary tract cancers and emerging targeted therapies.Emerging pharmacotherapeutic strategies for cholangiocarcinoma.Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.Chemotherapy for the biliary tract cancers: moving toward improved survival time.Role of chemotherapy in treatments for biliary tract cancer.Multimodality treatment of intrahepatic cholangiocarcinoma: A review.Signaling pathways as therapeutic targets in biliary tract cancer.GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP.Surgery and chemotherapy for intrahepatic cholangiocarcinoma.Adjuvant Gemcitabine-Oxaliplatin (GEMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma.Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
P2860
Q26784174-DE1B9833-9396-48D1-B377-C9C6480ACA67Q30234532-81FD6261-264C-4F55-95AA-0C8D05346D49Q30300756-8B8232DC-4890-4A84-AE76-3066B9AD0CD2Q33375557-2B500A36-DB32-4D87-88E6-C9DAAF880F12Q33391729-7236F19B-072D-4CA3-8D77-C8473C6F0171Q33420043-F67507F2-1AC9-41A9-87FF-761DEED7887BQ33977171-B5C9C77C-B802-49BF-B8C2-72C82645EF27Q34307050-F93327D7-DB6F-4EC9-937F-B3BB788C3577Q34551877-E102FC8B-81C1-4A59-9CCB-621A4A988370Q34588361-80F7E720-C97B-4ED8-A0FA-295F7290A64EQ35583920-F2885A61-B596-41A8-8064-3794E004BCEFQ35947011-CDBB39E7-DE19-46C4-89C0-9CBE60935FDAQ36459140-C76566F2-2083-456F-B904-B30836D7D88EQ36962011-58DC6EB9-A7CC-400F-BA5E-35F71E281218Q37132750-CCB51C3D-8B5B-4709-B4C4-C26F7FD18E4BQ37138732-93FC1380-9337-4C97-8CD4-ED15F0CE7C50Q37614142-58B597EC-16E3-493F-9068-720C41BD24E6Q37765099-884FDDD1-3CBB-4DB4-BF86-0F7944BF25E8Q37876403-3FA8E53D-E2F5-44CF-B794-3D817E3D93C3Q37977363-E2A18163-3DF4-45B3-86B0-01753DFE336FQ37983498-FA41BA46-158F-4FBF-950A-B1113885B6BBQ37997942-CA98EFBD-6F90-447B-84EE-E0E17315DAFCQ38707365-B19B45A7-9CA6-4329-A522-CE13D2E813B2Q38747573-5CA937C3-8825-410A-AD7D-3B52F930EB09Q38858942-AE50EDB5-C74B-45F8-8238-F419480C2138Q41140456-54D31FB9-BF32-4CFA-8635-8C86A5819A78Q47118575-4231C718-56DF-4378-B784-8AB07368DCD7Q50795703-0BF76895-74AC-421F-8DA4-395CEBF9E289
P2860
Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Capecitabine combined with gem ...... tatic biliary tract carcinoma.
@ast
Capecitabine combined with gem ...... tatic biliary tract carcinoma.
@en
type
label
Capecitabine combined with gem ...... tatic biliary tract carcinoma.
@ast
Capecitabine combined with gem ...... tatic biliary tract carcinoma.
@en
prefLabel
Capecitabine combined with gem ...... tatic biliary tract carcinoma.
@ast
Capecitabine combined with gem ...... tatic biliary tract carcinoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Capecitabine combined with gem ...... static biliary tract carcinoma
@en
P2093
Dong-Ki Lee
Jae Bock Chung
Se Joon Lee
Yong Han Paik
P2860
P304
P356
10.1002/CNCR.21591
P407
P577
2005-12-01T00:00:00Z